-
Citron On Lannett: Price Gouging At Its Worst, Will Be First To Go Bankrupt
Tuesday, January 17, 2017 - 1:26pm | 319Read More...Lannett Company, Inc. (NYSE: LCI) was trading lower by more than 5 percent Tuesday after Citron Research slammed the distributor of generic drugs in a new report. According to Citron, Lannett will become the first pharmaceutical company to go bankrupt and its equity is worth $13 to $15 a share...
-
Report: Teva Looking To Win Early EU Approval For Its Acquisition Of Allergan's Generics Unit
Wednesday, February 17, 2016 - 3:49pm | 201Read More...According to a report from Bloomberg, Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) is looking to win an early European Union approval for its $40.5 billion takeover of Allergan plc Ordinary Shares (NYSE: AGN)'s generics business. Reuters, citing "a person familiar with the...
